DYSF mutation analysis in a group of Chinese patients with dysferlinopathy
Introduction
Dysferlin is a 230 kDa transmembrane protein and has been shown to be involved in the process of membrane repair [1], myoblast differentiation [2], T tubulogenesis [3] and muscle regeneration [4] through mechanisms of membrane organisation. Dysferlinopathies refer to a group of autosomal recessive muscular dystrophies caused by mutations in DYSF. Mutations in DYSF lead to different clinical phenotypes of muscular dystrophy according the distribution of affected muscles. It encompasses limb-girdle muscular dystrophy (LGMD2B), Miyoshi myopathy (MM), distal myopathy with anterior tibial onset (DMAT), isolated hyperCK and rigid spine syndrome. LGMD2B is characterized by predominant weakness and atrophy of muscles of the pelvic and shoulder girdle, onset in the late teens or later. LGMD2B is the second more frequent form of LGMD in Western countries [5] and Japan [6]. In China, LGMD has not been adequately studied, and its epidemiology remains unclear. MM is an early-adult onset, distal muscular dystrophy, characterized by predominant involvement in the calf muscles [7]. DMAT is a distal muscular dystrophy, characterized by predominant involvement in the anterior compartment group [8]. There are very few reports regarding dysferlinopathy in the Chinese population. In this study, we performed mutation analysis of DYSF in 8 Chinese patients with a dysferlin protein deficiency; the clinical and pathological features were collected and analyzed.
Section snippets
Materials and methods
We analyzed 8 Chinese patients from 8 unrelated families. Inclusion criteria for patients were: (i) clinical phenotype consistent with LGMD or distal myopathy, and (ii) metabolic myopathies or congenital myopathies were excluded, and (iii) loss or strong reduction of dysferlin expression evidenced by immunohistochemistry on muscle biopsy.
Mutational analysis of the DYSF gene
We performed a genomic analysis of the DYSF coding sequence in 8 unrelated Chinese patients based on a marked or total loss of dysferlin expression in muscle, demonstrated by immunohistochemistry on muscle sections. We identified 6 different mutations that included one nonsense mutations; two deletions, two insertions and one splice site mutations. Five of them were novel mutations. Three patients carried a single homozygous mutation; one patient had two compound heterozygous mutations; three
Discussion
Mutations in DYSF cause different clinical phenotypes of muscular dystrophy and the distribution of affected muscles is different between patients. Some patients show onset in proximal muscles, while others show initial selective atrophy and weakness of calf muscles or anterior tibial muscles. DYSF gene mutation analysis was carried out in 8 Chinese patients, who had drastic or complete protein deficiency on muscle sections. We have identified 6 variations in the DYSF gene, 5 of them being
References (20)
- et al.
Absence of dysferlin alters myogenin expression and delays human muscle differentiation “In vitro”
Journal of Biological Chemistry
(2006) - et al.
Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients
Journal of the Neurological Sciences
(2003) - et al.
Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy
Clinical Neurology and Neurosurgery
(2006) - et al.
Novel DYSF mutations in Thai patients with distal myopathy
Clinical Neurology and Neurosurgery
(2009) - et al.
Defective membrane repair in dysferlin deficient muscular dystrophy
Nature
(2003) - et al.
Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle
Muscle and Nerve
(2010) - et al.
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
Human Molecular Genetics
(2009) - et al.
Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients
Human Mutation
(2008) - et al.
Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case
Brain
(1986) - et al.
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype
Annals of Neurology
(2001)
Cited by (11)
Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile
2023, Neuromuscular DisordersAnalysis of DYSF gene mutations in two pedigrees affected with limb-girdle muscular dystrophy type 2B
2018, Chinese Journal of Medical GeneticsAnalysis on clinical phenotype and gene mutation of three cases of dysferlinopathy in two families
2018, Chinese Journal of Contemporary Neurology and NeurosurgeryResearch progress of muscular diseases
2018, Chinese Journal of Contemporary Neurology and Neurosurgery